untitled
|
|
- あおい しどり
- 7 years ago
- Views:
Transcription
1
2 21 +
3
4 TC : Toatal Choelesterol TGtriglyceride CE : cholesterol ester VLDLvery low density lipoprotein IDLintermediate density lipoprotein LDL low density lipoprotein HDL high density lipoprotein FFAfree fatty acid NEFA Lp(a): lipoprotein(a) (a) LPLlipoprotein lipase HTGLhepatic triglyceride lipase TG CETP:cholesteryl ester transfer protein CE FHfamilial hypercholesterolemia TC
5 Chol (mg/dl) TG 0 C>B>A <0.96 VLDL 630 C>B>E ~1.006 LDL HDL B A >C ~1.063 ~1.125 VLDL LDL HDL
6
7
8
9 LDL- LDL-C LDL-CFriedewald Friedewald400mg/dl Friedewald LDL-CHDL-C
10 220mg/dL LDL HDL LDL HDL 140mg/dL 40mg/dL 150mg/dL
11
12
13
14
15
16 WHO β
17
18
19 β
20
21 TG 83% 52.2% 49.3% b 32.4% a 16.9% n= %,78,115,1990.
22 TG FFA TG TG= VLDL LPL LPL HDL VLDLsmall dense LDL
23 2
24 TGHDL-C LDL small dense LDL LDL LDL RLP-C
25
26
27 220mg/dL LDL HDL LDL HDL 140mg/dL 40mg/dL 150mg/dL
28 mg/dl LDL-C TC LDL-C HDL- C TG A B1 B2 B3 B C
29 B3B4 200 LDL120 HDL (120) C 180 LDL100 mg/dl
30
31 LDL-CHDL-CTG
32
33
34
35 * /3
36 1 2 III
37 LDL-C TC TG HDL-C
38 ll a ll b 700mg/dl EPA
39 HMG-CoA LDLC TG HDLC. CYP A C A Medical View Points 22(10)2001
40
41 pleiotropic effects
42 LDL JAMA 2001;285:
43 cm cm mgdl HDL mgdl mmhg mg mgdl Diabetes & Endocrine Division, Kawasaki Medical School
44 CT
45 p p p for linear trend p = p for linear trend p =
46 Diabetes & Endocrine Division, Department of Medicine, Kawasaki Medical School
47 Diabetes & Endocrine Division, Department of Medicine, Kawasaki Medical School
48
49 µ µ µ µ Diabetes & Endocrine Division, Department of Medicine, Kawasaki Medical School
50 Diabetes & Endocrine Division, Department of Medicine, Kawasaki Medical School
51 62mm 48mm Diabetes & Endocrine Division, Kawasaki Medical School
52 LDLCFH atorvastatin 20mg, probcol 1000mg LDL mg/dl Diabetes & Endocrine Division, Kawasaki Medical School
53 Diabetes & Endocrine Division, Department of Medicine, Kawasaki Medical School
54 Diabetes & Endocrine Division, Department of Medicine, Kawasaki Medical School
55 PAGE Diabetes & Endocrine Division, Department of Medicine, Kawasaki Medical School
56 Diabetes & Endocrine Division, Department of Medicine, Kawasaki Medical School
57 LPL Diabetes & Endocrine Division, Department of Medicine, Kawasaki Medical School
58 LPL C 2
20-121
20 121 150 1 20 121 1 HbA1C 1 2 2 HbA1C 3 2 4 5 HbA1C 1 HbA1C -NH2 -CHO HbA1C 1 1 HbA1C HbA1C HbA1C HbA1C HbA1C 120 HbA1C HbA1C 1 2 2 HbA1C 120 10 10 10 3 β β 1 1 GAD ICA 2 4 HbA1C 2 1 2 5 2 20 121 150
More information[] 1
0 [] 1 [] 2 [] 2010 22 0% 20% 40% 60% 80% 100% 15.4 65.2 10.8 8.6 12,000 2010 22 2020 32 2030 42 2040 52 2015 27 14.3 63.3 12.3 10.1 10,000 2020 32 13.2 63.0 11.9 11.9 8,000 2025 37 12.3 62.9 10.6 14.2
More information2
1 2 3 TG T-cho 4 TG 10 Triglyceride (mg/dl) 400 350 300 250 200 150 T-cho 100 50 B 0 B B B Pre 2 4 6 8 10 12 After feeding (hr) B B B 5 HPLC 6 HPLC 152-0034 1-5-22-201 Tel. 03-5731-3630 / Fax. 03-5731-3631
More informationuntitled
Metabolic syndrome,,,, 81 81 , 17 17 2 Lung Ca non small cell carcinoma / / food( food( ) drug( drug( ) 100mg 750mg WBC 5510/ l RBC 483 / l Hb 10.3g/dl, Ht 42.0% Plt 19.0 / l TP 8.1g/dl Alb 4.6g/dl Glb
More information函館市_絵で見てわかる
70 75 26 2 27 1 2 3 4 5 6 7 8 9 4 6 6 6 8 10 10 10 10 12 21 21 22 26 28 30 32 34 36 2 3 70 75 701 28 75 6575 7075 28 75 3 4 5 75 65 26 28 75 65 75 1 1 70 7075 2 2 2 1 260 90 210 18 9012 160 18 100 183
More information1990 1010 21 (1)(2) (3) (4) Vol. 21 No. 111999 3
201980Japan as number one 21American as number one 20 198020 19701980 1980 1990 2 Vol. 21 No. 111999 1990 1010 21 (1)(2) (3) (4) Vol. 21 No. 111999 3 SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSS
More informationPX-047A Series
B K L & L & A B C D E F A B A B C A B C A B A B A B C D E F G P BB H I y y & & K L L & & K L L L L & & & & L d L & & & & L L & & & L & & & & L & & & & & & & & L L L L L L & & & A B C D E F G
More informationA B 1.A B A B 2.A B A B 3.A
1 1. 2.WHO 3. 4. 5. 2 2.0mg/kg / 1. 2. 3. 4. 5. 3 1. 90 2. 3. 4. 5. 4 1. 2. 3. 4. 5. 1 21 5 1. 2. 2050 61 3. 1 4. 5. 6 1. ----------- 2. ---- 3. ------ 4. -------- 5. --------- 7 A B 1.A B------------------A
More information21 70.9 22 62.9 22 90 80 60 40 23 58 17 42 31 77.5 9 22.5 1 n 40 40 0 2 2 5.0 50 0 3 3 7.5 60 3 12 15 37.5 70 12 5 17 42.5 80 1 1 2 5.0 90 1 0 1 2.5 4
462015 Nagoya community school for health Think health scientifically : the life style and the health condition of seminar participants Hisae USAMI 21 36 67 1/3 21 21 21 1 23 6 68.2 91 43 70 42.56037.5
More information0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2
24 11 10 24 12 10 30 1 0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2 23% 29% 71% 67% 6% 4% n=1525 n=1137 6% +6% -4% -2% 21% 30% 5% 35% 6% 6% 11% 40% 37% 36 172 166 371 213 226 177 54 382 704 216
More information10 117 5 1 121841 4 15 12 7 27 12 6 31856 8 21 1983-2 - 321899 12 21656 2 45 9 2 131816 4 91812 11 20 1887 461971 11 3 2 161703 11 13 98 3 16201700-3 - 2 35 6 7 8 9 12 13 12 481973 12 2 571982 161703 11
More informationPhD HIPAA sports nutrition coach ACE ISSN Sports Nutrition Specialist Certification ISSN CISSN IOC IOC 3
1 9 2017-05-06 Marie Spano, MS, RD 185 AND CSSD 2 9 2017-05-06 PhD HIPAA sports nutrition coach ACE ISSN Sports Nutrition Specialist Certification ISSN CISSN IOC IOC 3 3 136 EPA D 46 B12 B12 B12 2010 98
More informationBMI BMI
() () 2 QOL () () QOL 11 6 14 20 13.9 20 BMI 12 70 40 11 6 14 20 13.9 20 BMI 12 70 40 57.1 100 ) 1 100 1 250 11 11 430 315 73.3 494 247 50.0 322 60 18.6 12 70 62 88.6 100 18 57.1 1 100 1 250 430 315 73.3
More informationSample2 g/dl Target1 : 6.01 g/dl TP Target2 : 8.39 g/dl
( ) Sample2 g/dl 10 9 8 7 6 Target1 : 6.01 g/dl TP Target2 : 8.39 g/dl 117 5.92 0.09 1.6 118 5.92 0.10 1.6 7 5.77 0.14 2.4 118 8.28 0.15 1.8 118 8.28 0.15 1.8 7 7.26 0.46 6.4 119 119 6.84 7.10 0.11 0.11
More informationcm H.11.3 P.13 2 3-106-
H11.3 H.11.3 P.4-105- cm H.11.3 P.13 2 3-106- 2 H.11.3 P.47 H.11.3 P.27 i vl1 vl2-107- 3 h vl l1 l2 1 2 0 ii H.11.3 P.49 2 iii i 2 vl1 vl2-108- H.11.3 P.50 ii 2 H.11.3 P.52 cm -109- H.11.3 P.44 S S H.11.3
More information2015taisetumatome.rtf
B B B( ) B3 - B3 1 3g 1/3 B 1. B1() B1() 2. B2() B2() 3. B5() B5() 4. B6() B6()( ) 5. B12() B12() 6. 1q60 160m 50m 50m 20m 8520 80 10 64 5075 30 80 B B 1 30 BB BC EPA . ?? 6 C E C 1 30 1 0.4mg4
More information12-7 12-7 12-7 12-7 12-8 12-10 12-10 12-10 12-11 12-12 12-12 12-14 12-15 12-17 12-18 10 12-19 12-20 12-20 12-21 12-22 12-22 12-23 12-25 12-26 12-26 12-29 12-30 12-30 12-31 12-33 12-34 12-3 12-35 12-36
More informationBAANs理論に基づく保健指導プログラム暫定版
WHO 4 5 10% L- -3 RNA L - 1960-3 RNA mrna Bio Activating Advanced Nutrients BAANs BAANs BAANs BAANs L- (NO) -3 EPA, DHA) RNA RNA DNA TNF- PAI-1 ( ) BAANs 40 50% 20% 1Kg 7,000Kcal 50Kcal 11 50Kcal
More informationMicro-D 小型高密度角型コネクタ
Micro- 1 2 0.64 1.27 1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 1 2 3 4 5 6 7 8 9 10 11 12 13 1.09 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 3 4 J J
More information8 8 0
,07,,08, 8 8 0 7 8 7 8 0 0 km 7 80. 78. 00 0 8 70 8 0 8 0 8 7 8 0 0 7 0 0 7 8 0 00 0 0 7 8 7 0 0 8 0 8 7 7 7 0 j 8 80 j 7 8 8 0 0 0 8 8 8 7 0 7 7 0 8 7 7 8 7 7 80 77 7 0 0 0 7 7 0 0 0 7 0 7 8 0 8 8 7
More informationarakidonsan.rtf
DHA (ARA) ARA DHA 50 DHA 20 DHA( ) γ 300 mg 170 mg 150 mg 78 mg 57 mg 3,200 mg 2,300 mg 1,700 mg 1,700 mg 1,700 mg β- E FAO DHA( ARA) DHA 2ARA 1 DHA 70mg 100g 35mg 100g 6 6 63 EPA DHA 63 6 EHA DHA 50 WEB
More information1. (1) 1/
2005 11 30 2006 03 31 1-1-2 [ ] 7-12 SMBC 4 1 27 1 18 1. (1) 1/5 1 2 32 1/5 1 2006 3 11 200 2006 1 1/5 20 20 30 CM 10 TVCM15 BB 2006 3 31 26 3 5 2 1 4 3 2 3 (2) (1) 2. (1) 1 2006/03/31 1,680,877,606 1
More informationLow density lipoprotein(LDL)アフェレシス
Low density lipoprotein LDL 1 2 1 2 Hisashi MAKINO, Mariko HARADA-SHIBA 1. はじめに Low density lipoprotein LDL 著者連絡先 565-8565 5-7-1 E-mail. mshiba@ncvc.go.jp familial hypercholesterolemia; FH LDL FH LDL 600
More informationLDL HbA1c6. 5% AST51 ALT51 - GT LDL180 1, mmHg 85mmHg 150mg/dL HDL 40mg/dL 100mg/dL HbA1c 5.6% mmhg mg/dl mg/
30 7 IT 28 335 704 4 16 40-74 1 3 1100cm 2 100cm 2 BMI25kg/m 2 285cm 90cm 385cm 90cm BMI25kg/m 2 130mmHg 140mmHg 85mmHg 90mmHg 150mg/dL 300mg/dL HDL 39mg/dL 34mg/dL LDL 120mg/dL 140mg/dL 100mg/dL 126mg/dL
More information14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0
More informationP1-1 P1-2 P1-3 P1-4 P1-5 P1-6 P3-1 P3-2 P3-3 P3-4 P3-5 P3-6 P5-1 P5-2 P5-3 P5-4 P5-5 P5-6 P7-1 P7-2 P7-3 P7-4 P7-5 P7-6 P9-1 P9-2 P9-3 P9-4 P9-5 P9-6 P11-1 P11-2 P11-3 P11-4 P13-1 P13-2 P13-3 P13-4 P13-5
More information日本消化器病学会雑誌第102巻第8号
χ χ χ χ χ χ χ χ β The Health Administration Center, Tohoku University ; Department of Gastroenterology, Tohoku University Hospital Department of Endoscopic Diagnostics and Therapeutics, Chiba University
More information研修コーナー
l l l l l l l Department of Obstetrics and Gynecology, Fukui Medical University, Fukui l l l l l l µ l β β l α l µ µ l l l l Department of Obstetrics and Gynecology, Gifu University School of Medicine,
More information56cm 1 15 1960 2 8 2 2 1 2008 1992 2 1992 2 3562mm 3773mm 2 1980 1991 2008 2007 2003 5 2 3 2003 2005 2008 2010 2005 2008 2012 2010 2012 4 7 4 5 2 1975 1994 8 2008 NPO 2 2010 3 2013 2016 3 2008 2009 14
More information1 913 10301200 A B C D E F G H J K L M 1A1030 10 : 45 1A1045 11 : 00 1A1100 11 : 15 1A1115 11 : 30 1A1130 11 : 45 1A1145 12 : 00 1B1030 1B1045 1C1030
1 913 9001030 A B C D E F G H J K L M 9:00 1A0900 9:15 1A0915 9:30 1A0930 9:45 1A0945 10 : 00 1A1000 10 : 15 1B0900 1B0915 1B0930 1B0945 1B1000 1C0900 1C0915 1D0915 1C0930 1C0945 1C1000 1D0930 1D0945 1D1000
More information2
5 15.8% 17.1% 13.7% 15 1 34.0%3 1 3 25.7 4 1 76.5 3.3 2 23 3225 36 72.0 13.3 1 26 38 ( 77.8 87.8 69.5 2010 3 20 60 7 20 2 3 1 2 ( 77.8 87.8 69.5 2010 87.9 66.5 3 20 83.030 92.240 93.6 50 91.660 6065 72.9
More informationBUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI
20 2 2015 1 2 3 85 K CT Abstract A case of renal subcapsular hematoma resulting from trigger point injection under excessive effect of anticoagulant YAMANE Tateki, UMEDA Akira and SHIMAO Hitoshi An 85-year-old
More informationEPSON
B K L & & & & & & & & L & & & & & & & K & & & & & L L L & & & K L L L & & L L L & & & & & & & & & & & & & & & & & & & & & & & & & & & L & K L K & & & & & & & L L & & L & & L L & & & & &
More information2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1
2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1 16 24 21 20 20 23 10 11 9 10 3 3 3 2 3 1 3 4 6 8 2 0 1 2 3 4 5 6 0 1 2 3 4 5 6 0 1 2 3 4 5 6 3 4 Q & A Q1 A1 Q2 A2 Q3 A3 7
More informationQ&A最低資本金特例030131.PDF
& 1 2 2 3 2 2 3 2 2 3 10 11 10 90 12 13 14 15 16 17 18 19 20 2 2 3 21 2 2 3 22 23 24 25 20 10 26 27 28 10 8 1 29 30 10 8 2 31 32 2 2 3 33 10 8 3 10 11 2 34 10 8 3 10 12 2 35 36 20 10 37 38 39 40 41 42
More informationbumon_pro.indd
q w e r t y u i o!0 !1!2!3 !4!5!6 !7!8!9 @0 @1 @2 @3 @4 @5 @6 @7 @8 @9 #0 #1 #2 #3 #4 #5 #6 #7 #8 #0 $0 $1 $2 $3 $4 $5 $6 $7 $8 $9 %0 %1 %2 %3 %4 %5 %6 %7 %8 %9 ^0 ^1 ^2 ^3 ^4 ^5 ^6 ^7 ^8 ^9 &0 &1 &2
More information2012_10_A_cover.indd
c %& r Z \ W n % & & % % & % & & % % % & % & % & & % & % %& % & % & % % % & & & W W W W A
More information‡o‡P†C‡P‡Q”R„û†^‡P†C‡P‡Q
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Q & A ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
More information2012_05_GLK_cover.indd
c %& r Z \ W W n q & F % % & & % & & % % % & % & % & % & % & % & F F % % % & & & & % & A
More information™…
2/10 15 2010. No1362 1 1 216315 91430 Q A & 0.23% 1 1.4% 04-7120-2020 050-5540-2023 Q A & 1 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 1 2 3 4 5 6 7 8 9 10
More information2.
2. 10 2. 2. 1995/12006/111995/42006/12 2. 10 1995120061119954200612 02505 025 05 025 02505 0303 02505 250100 250 200 100200 5010050 100200 100 100 50100 100200 50100 10 75100100 0250512 02505 1 025051205
More information日本内科学会雑誌第106巻第4号
特集 脂質異常症 : 実地診療におけるピットフォールから未来の治療まで 動脈硬化リスク 治療標的としての TG,HDL 要旨 高トリグリセライド (triglyceride:tg) 血症, 低 HDLコレステロール (high density lipoprotein-cholesterol:hdl-c) 血症はそれぞれ動脈硬化促進因子である. 高 TG 血症ではレムナントやsmall dense LDL(low
More information“÷Œò›ï46
46 1 1 50.1 2 34 kgkg100 XCT100cm 2 2005 1100cm 2 85 cm90 cm 5 5 1 2 6OSCE OSCE 7 8 9 13 14 16 17 17 20 18 19 22 23 25 19 26 6 BMI 4.0g/ml 6 2 7 RIA EIA 8 3.10.3 ng/ml 7.91.2 ng/ml 2 7401620 2002 9 11
More informationMicrosoft Word - 表紙資料2-4
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
More informationuntitled
. 23 3 2 1 2 3 21 21 22 9 1 23 18 4 5 6 5 40 20 7 1 1 8 9 10 11 12 50cm 13 10 11 14 2011 3 11 15 16 ml mm tel 079-557-0039 & fax 079-557-1888 17 248-240- 98-48- 170-98- 98- ml 85-1,085-18 19 20 21 22 23
More information2001 2003 2005 2006 2007 2008
2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65
More information<4D F736F F D208C C9F8DB8926C82A982E782DD82BD89C193FC8ED282CC8C928D4E8FF391D482C98AD682B782E992B28DB895AA90CD2E646F6378>
28 6 IT 26 1 326 4,499 433 40-74 100cm 2 100cm 2 BMI25kg/m 2 85cm90cm 85cm90cm BMI25kg/m 2 130mmHg 140mmHg 85mmHg 90mmHg 150mg/dL 300mg/dL HDL 39mg/dL 34mg/dL LDL 120mg/dL 140mg/dL 100mg/dL 126mg/dL HbA1c
More information......1201-P1.`5
2009. No356 2/ 5 6 a b b 7 d d 6 ca b dd a c b b d d c c a c b - a b G A bb - c a - d b c b c c d b F F G & 7 B C C E D B C F C B E B a ca b b c c d d c c d b c c d b c c d b d d d d - d d d b b c c b
More information広報さっぽろ 2016年8月号 厚別区
8/119/10 P 2016 8 11 12 P4 P6 P6 P7 13 P4 14 15 P8 16 P6 17 18 19 20 P4 21 P4 22 P7 23 P6 P7 24 25 26 P4 P4 P6 27 P4 P7 28 P6 29 30 P4 P5 31 P5 P6 2016 9 1 2 3 P4 4 P4 5 P5 6 7 8 P4 9 10 P4 1 b 2 b 3 b
More information<4D F736F F D2095BD90AC E93785F8C C9F8DB8926C82A982E782DD82BD89C193FC8ED282CC8C928D4E8FF391D482C98AD682B782E992B28DB895AA90CD2E646F6378>
29 7 IT 27 339 5,199 464 40-74 100cm 2 100cm 2 BMI25kg/m 2 85cm90cm 85cm90cm BMI25kg/m 2 130mmHg 140mmHg 85mmHg 90mmHg 150mg/dL 300mg/dL HDL 39mg/dL 34mg/dL LDL 120mg/dL 140mg/dL 100mg/dL 126mg/dL HbA1c
More informationビットリアカップ2007けいはんなサイクルレースリザルト
Page 4/30 Page 5/30 Page 6/30 Page 7/30 Page 8/30 Page 9/30 Page 10/30 Page 11/30 Page 12/30 Page 13/30 Page 14/30 Page 15/30 Page 16/30 Page 17/30 Page 18/30 Page 19/30 Page 20/30 Page 21/30 Page 22/30
More informationPage 1
Page 1 Page 2 Page 3 Page 4 620 628 579-41 -6.7-49 -7.9 71 41 47-24 -33.3 6 15.9 11.5 6.5 8.1 36 15 22-14 -38.9 7 43.4 Page 5 277 302 23 24 12/3Q 12/4Q 13/1Q 13/2Q 13/3Q 13/4Q 14/1Q 14/2Q 14/3Q 14/4Q 15/1Q
More information●70974_100_AC009160_KAPヘ<3099>ーシス自動車約款(11.10).indb
" # $ % & ' ( ) * +, -. / 0 1 2 3 4 5 6 7 8 9 : ; < = >? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y " # $ % & ' ( ) * + , -. / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B
More informationからだにeヘルシーレシピ 高血圧
We b e 3,5 00 7day 1. 2. & 3. 1 C O N T E N T S 2.6 0 1 0 5 0 7 1 0 9 17 2 2 2 3 CHECK&POINT! 2 5 24 1 2 7 e 2 9 e 3 1 webe 3 3 6 12 18 24 6 16 16g 111 1 6 1 2010 2010 18 20 3,970 18 1 400 2.6 01 02 140mmHg
More information第4回クッキーテスト研究会研究報告集(PDF)
2007 H19.8 2007 5 26 () 2 3 7 9 12 14 15 18 25 29 1 2 () (g g kcal) mg/dl.mg/dl ( U/mlhr).(mg/dl*U/ml) 50.2 158.6cm 70.7kg 28.1kg/ 92.5cm ( ) () ( ) (.(.-.)g/ml.(-.) g/ml ((MS) MS MS cm 2 MS () 3 4 122/74
More information高脂血症の検査
35 30 Buffy coatbuffy coat EDTA Na Na Ca RBC Hb Ht WBC Plt ESR TP Alb CRP GOTGPTLDH BUN Cre UA HbA1C TC TG NaKClCaPFe B12 36 RBC 410530 /μl 380480 /μl Hb 13.517.6g/dL 11.315.2g/dL Ht 3648% 3443% MCV MCH
More informationuntitled
5 K 5 3 HP http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/taikou03.html 2004 1 2 1 http://www.dm-net.co.jp/calendar/2007/06/005835.php 6 85cm 100cm 2 90cm 2 TG 150mg/dl HDLHDL-C 40mg/dl 130mmHg 85mmHg
More information